Aileron Therapeutics Inc - Wutah bathi EPS kuartalan ALRN

Logo korporat perusahaan Aileron Therapeutics Inc (ALRN)

The viability of Aileron Therapeutics (ALRN) relies on access to capital and the results of specialized oncology research. This quarterly earnings per share chart illustrates the trend of fundamental outcomes, where the value is recorded at 70.30. The efficiency of developing targeted therapies is increasing through the use of robotic systems and AI. The company is currently focusing on R&D, seeking partners to license its assets.

Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan aileronrx.com (ALRN): kanggo periode 04.07.2022 - 17.11.2026

Rincian analitis perusahaan Aileron Therapeutics

- rega saham lan konsensus proyeksi valuasi:
Pambiji fundamental perusahaan:Aileron Therapeutics Inc - ALRN
Barang unggulan Aileron Therapeutics, Inc.

This indicator measures the dynamics of net earnings per share, allowing for an assessment of the business's ability to scale profitability relative to operating expenses and inflationary pressure on payroll. By analyzing the quarterly growth rate of earnings per share, an investor can determine how effectively laboratory robotics and AI implementation at Aileron Therapeutics (ALRN) are reducing routine costs, transforming technological automation into tangible financial results.

Analisis perusahaan pesaing

GMAB (Genmab) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|EXEL: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|NUVL (Nuvalent Therapeutics) - Wutah bathi EPS kuartalan|Wutah bathi EPS kuartalan kymeratx.com|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan IDEAYA Biosciences, Inc. (IDYA)|ELVN (Enliven Therapeutics, Inc.) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan ORIC (ORIC Pharmaceuticals Inc)|Wutah bathi resik saben saham sajroning taun lumaku Relay Pharma|Nurix Therapeutics Inc - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Tyra Biosciences|VSTM (Verastem, Inc.) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|GLUE: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|CGEM (cullinanoncology.com) - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Immuneering Inc. IMRX|Wutah bathi EPS kuartalan CCCC|Black Diamond Therapeutics - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|Repare Therapeutics Inc. - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan PMVP|KPTI: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|propanc.com - Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|BGMS: Wutah bathi EPS kuartalan|Aadi Bioscience Inc - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|BPMC (Blueprint Medicines Corp.) - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan glycomimetics.com GLYC|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan SpringWorks (SWTX)